These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. New human T-lymphotropic retrovirus related to simian T-lymphotropic virus type III (STLV-IIIAGM). Kanki PJ, Barin F, M'Boup S, Allan JS, Romet-Lemonne JL, Marlink R, McLane MF, Lee TH, Arbeille B, Denis F. Science; 1986 Apr 11; 232(4747):238-43. PubMed ID: 3006256 [Abstract] [Full Text] [Related]
10. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972). Saxinger C, Levine PH, Dean A, Lange-Wantzin G, Gallo R. Cancer Res; 1985 Sep 11; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697 [Abstract] [Full Text] [Related]
13. [LAV type II: a second retrovirus associated with AIDS in West Africa]. Clavel F, Brun-Vézinet F, Guétard D, Chamaret S, Laurent A, Rouzioux C, Rey M, Katlama C, Rey F, Champelinaud JL. C R Acad Sci III; 1986 Sep 11; 302(13):485-8. PubMed ID: 3013382 [Abstract] [Full Text] [Related]
14. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Chen Z, Gettie A, Ho DD, Marx PA. Virology; 1998 Jun 20; 246(1):113-24. PubMed ID: 9656999 [Abstract] [Full Text] [Related]
15. Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection. Sarngadharan MG, diMarzo Veronese F, Lee S, Gallo RC. Cancer Res; 1985 Sep 20; 45(9 Suppl):4574s-4577s. PubMed ID: 2410106 [Abstract] [Full Text] [Related]
16. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells. Rook AH, Lane HC, Folks T, McCoy S, Alter H, Fauci AS. J Immunol; 1987 Feb 15; 138(4):1064-7. PubMed ID: 3027168 [Abstract] [Full Text] [Related]